United States · Investor

Pappas Ventures

Last cheque observed Aug 2016. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietVC firmNow at pappas-capital.com

Series ASeries BSeries CB2BStock ExchangesLife Science

Cheques on record
0%of best year0cheques in 12 months, 42 on record
Since the last cheque3723days00hrs00min00sec
Median round$16MRounds led0 of 42Exits6 from the portfolioMostly inUnited States, 90%
Pitch Pappas Ventures

Pappas Ventures highlights

  1. 01

    42 rounds on record

  2. 02

    Mostly Series A and Series B: 50% of its rounds

  3. 03

    6 exits from the portfolio

What they do

Type
VC firm (from a list, unverified)
Cheque size
Not stated
Sectors
B2BStock ExchangesLife Science
Based in
United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first42 appearances

  1. 2016

    2 rounds

  2. Aug
    Rotation MedicalSeries B · US · FinSMEs$12MWith 1 other
  3. Feb
    AgTech Accelerator$20MWith 9 others
  4. 2015

    3 rounds

  5. Jun
    Milestone PharmaceuticalsSeries B · CA$17MWith 5 others
  6. Mar
    Balance TherapeuticsSeries A · US$18MWith 2 others
  7. Jan
    CoLucid PharmaceuticalsSeries C · US$37MWith 7 others
  8. 2014

    2 rounds

  9. Jul
    Rotation MedicalSeries B · US$27MWith 2 others
  10. Mar
    Lumena PharmaceuticalsSeries B · US$45MWith 6 others
  11. 2013

    4 rounds

  12. Nov
    Envisia TherapeuticsSeries A · US · ca.finance.yahoo.com$25MWith 4 others
  13. Nov
    Research Triangle Park (RTP)Series A · US · fiercebiotech.com$25MWith 3 others
  14. May
    Lumena PharmaceuticalsSeries A · US · reuters.com$23MWith 2 others
  15. Apr
    Afferent PharmaceuticalsVenture · US$5.0MWith 1 other
  16. 2012

    6 rounds

  17. Dec
    Ultragenyx PharmaceuticalGrowth · US · globenewswire.com$75MWith 6 others
  18. Oct
    ThrasosSeries C · CA · businesswire.com$35MWith 6 others
  19. Oct
    CardioDxGrowth · US$6.0MWith 3 others
  20. Sept
    IlluminOss MedicalSeries C · US · marketwire.com$28MWith 8 others
  21. Jul
    CardioDxGrowth · US$31MWith 13 others
  22. Feb
    CeNeRx BioPharmaSeries D · US · onbiovc.com$4.6MWith 2 others
  23. 2011

    6 rounds

  24. Aug
    CoLucid PharmaceuticalsSeries B · US · prnewswire.com$7.5MWith 4 others
  25. Jun
    TESAROSeries B · US · finsmes.com$101MWith 4 others
  26. Jun
    Ultragenyx PharmaceuticalSeries A · US · finsmes.com$45MWith 4 others
  27. Jun
    Milestone PharmaceuticalsVenture · CA · money.msn.com$13MWith 2 others
  28. May
    CardioDxGrowth · US · finsmes.com$60MWith 12 others
  29. Feb
    ChimerixSeries F · US · chimerix-inc.com$45MWith 7 others
  30. 2010

    7 rounds

  31. Dec
    TyRx PharmaVenture · US · tyrx.com$20MWith 2 others
  32. Aug
    Achillion PharmaceuticalsVenture · US · ir.achillion.com$50MWith 3 others
  33. Aug
    CeNeRx BioPharmaSeries C · US · cenerx.com$13MWith 2 others
  34. Jul
    Liquidia TechnologiesSeries C · US · onbiovc.com$5.0MWith 4 others
  35. May
    CardioDxSeries D · US · onbiovc.com$35MWith 7 others
  36. Mar
    Syndax PharmaceuticalsSeries A · US · onbiovc.com$9.0MWith 4 others
  37. Jan
    Liquidia TechnologiesSeries C · US · finsmes.com$20MWith 4 others
  38. 2009

    3 rounds

  39. Dec
    Afferent PharmaceuticalsSeries A · US · finsmes.com$23MWith 3 others
  40. Aug
    BarosenseSeries D · US · deals.venturebeat.com$27MWith 8 others
  41. Aug
    BiosyntechVenture · CA · biosyntech.com$1.4MWith 3 others
  42. 2008

    3 rounds

  43. Aug
    Anthera PharmaceuticalsVenture · US$19MWith 5 others
  44. Jul
    CoLucid PharmaceuticalsSeries B · US$25MWith 4 others
  45. Mar
    BrainCellsSeries B · US · venturebeat.com$30MWith 5 others
  46. 2007

    6 rounds

  47. Nov
    LEAD TherapeuticsSeries A · US · leadtherapeutics.com$17MWith 2 others
  48. Oct
    OptherionSeries A · US$37MWith 6 others
  49. Aug
    FlowCardiaSeries C · US · flowcardia.com$30MWith 8 others
  50. Jun
    GentisSeries A · US · venturebeat.com$10MWith 3 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 7 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What they claim to have backed

From their own portfolio page (on their website)

1 of 4 we have independently watched raise

bioNVCAWebtoffeenc-biotech

Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.

Exits from the portfolio

Companies it backed that were later bought or listed6 in all

Lumena PharmaceuticalsBought by Shire$260MMay 2014
TyRx PharmaBought by Medtronic$160MJan 2014
BarosenseBought by Boston ScientificUndisclosedJul 2013
TESAROListedUndisclosedMar 2012
FlowCardiaBought by C. R. BardUndisclosedMay 2010
Anthera PharmaceuticalsListedUndisclosedMar 2010

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Pappas Ventures. A count of rooms they were both in, not a relationship either has claimed.

Domain AssociatesVC firm10rounds togetherNew Enterprise AssociatesVC firm7rounds togetherAsset Management VenturesVC firm5rounds togetherCanaanVC firm5rounds togetherKleiner Perkins Caufield & ByersVC firm5rounds togetherMohr Davidow VenturesVC firm4rounds togetherMorningside GroupVC firm4rounds togetherAlta PartnersVC firm3rounds togetherCare CapitalGrowth equity3rounds togetherEQT life sciencePrivate equity3rounds togetherFonds de solidarite FtqVC firm3rounds togetherFrazier Healthcare PartnersPrivate equity3rounds together

Quick answers about Pappas Ventures

What does Pappas Ventures invest in?

Pappas Ventures invests most often at Series A and Series B (50% of the rounds on record), in sectors such as B2B, Stock Exchanges and Life Science.

How active is Pappas Ventures?

42 investments on record, 0 of them in the last 12 months. The most recent was in Aug 2016.

What has Pappas Ventures invested in recently?

Its most recent investments on record: Rotation Medical (Series B, Aug 2016) and AgTech Accelerator (Feb 2016).

How big are Pappas Ventures's cheques?

The median round it joins is $16M.

Does Pappas Ventures lead rounds?

Rarely, if at all: none of its 42 investments on record names it as the lead.

Where does Pappas Ventures invest?

Most of the companies it backs are in the United States (90%) and Canada (10%).

Is Pappas Ventures investing now?

No investments in the last 12 months; the latest was in Aug 2016.

Who does Pappas Ventures invest alongside?

Most often Domain Associates (10 rounds together), New Enterprise Associates (7 rounds together) and Asset Management Ventures (5 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it